HIV/AIDS News

  • Alert FDA Approves First Generic Truvada in US Generic versions of emtricitabine/tenofovir disoproxil, which can both treat and prevent HIV infections, are already available in other countries.
 
  • Alert FDA Approves 4th-Generation Latent TB Blood Test The FDA approved a fourth-generation latent tuberculosis (TB) blood test combining CD4/CD8 design to complete comprehensive immune response detection with the most adaptable blood collection workflow.
  • Rural East African Communities Achieve HIV Suppression Targets Community efforts in rural East Africa to implement universal testing and treatment have resulted in achievement of HIV viral suppression above target levels established by UNAIDS.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • ACOG Guidance: Individualize Breast Cancer ScreeningDecisions on when to start and end screening and on screening frequency should be made jointly by patients and providers, given the wide variation in major guidelines, ACOG said.
  • One Nut Allergy Doesn't Rule All Nuts OutContrary to past thinking, it isn't always necessary for someone with a nut allergy to dodge all nuts and seeds, and avoidance might even prompt more allergies, researchers warn.
  • Lying Flat vs Sitting Up: No Difference in Stroke OutcomesThe HeadPoST study -- showing no difference in disability outcomes in stroke patients who were laid flat vs those sitting up for the first 24 hours -- has now been published in the New England Journal of Medicine.

Perspective

Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Columnists

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape